Atrium Therapeutics, Inc. RNA

IPO $8.32 $0.273.35% NASDAQ
IPO Score
IPO Date
Feb 28, 2026
Recommendation
Dividend Power Score
Day's Range
$8.05$8.39
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our IPO Factors
Get Access

RNA IPO Factors

Debt Ratio
Growth Ratio
Industry
Institutional Support
Investment
IPO Size
Management
Market Reaction
Profitability
Revenue
Revenue Growth
Syndicate Size
Valuation

RNA Company Overview

Data inconclusive based on available public sources regarding an entity formally identified as “Atrium Therapeutics, Inc.” trading under the ticker symbol “RNA.” Reviews of publicly available corporate registries, major exchange listings, and commonly referenced financial databases do not consistently identify a currently listed company matching both the corporate name and ticker combination. The ticker “RNA” has been associated in public markets with other biotechnology companies at different points in time, creating potential ambiguity.

Because the company identity could not be conclusively verified through publicly available filings, exchange records, or major financial publications, a factual overview of the company’s products, industry positioning, customer segments, and historical development cannot be reliably provided without risking inaccurate attribution. Data inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.
Sector

RNA Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--

RNA Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

RNA Cash Flow

Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--

RNA Price History

Loading...
52-Week Range9% of range
Current
$8.32
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--

RNA Valuation

Market Cap
Market Cap Rank
#10,556
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

RNA Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

RNA Corporate Info

Phone Number
619 876 0700
Address
10578 Science Center Drive
Suite 125
San Diego, CA 92121
Country
Year Founded

RNA Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Feb 15 and 19 (est)

RNA Headlines